NCT06712576

Brief Summary

In recent years, with the application of an abdominal artery balloon and the improvement of surgical techniques, efforts are made to preserve the uterus for patients PAS. the aim of the study To evaluate conservative surgical management of placenta accreta spectrum in Assiut University hospital regarding maternal and fetal outcomes.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 27, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 2, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

December 2, 2024

Status Verified

November 1, 2024

Enrollment Period

1 year

First QC Date

November 27, 2024

Last Update Submit

November 29, 2024

Conditions

Keywords

planned conservative surgical managemen

Outcome Measures

Primary Outcomes (1)

  • amount of blood loss

    amount of blood loss during operation according to number of towels and amount of blood in suction pump

    baseline

Study Arms (1)

patients with placenta accrete spectrum

patients with placenta accrete spectrum secondary to previous cesarean section will be recruited from the outpatient clinic and reception unit, Assiut, Egypt.

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with placenta accrete spectrum secondary to previous cesarean section and Gestational age above 28 weeks

You may qualify if:

  • Pregnant women with history of previous caesarean section.
  • Age above 18 years.
  • Gestational age above 28 weeks.
  • U/S signs suggestive of placenta previa accreta.
  • Confirmed diagnosis of Placenta previa accreta spectrum disorder by 3 D U/S, Doppler or MRI if needed.

You may not qualify if:

  • Gestational age less 28 weeks.
  • Age less than 18 years.
  • Patients with known bleeding disorders.
  • Multiple pregnancy.
  • Other pathology (fibroid, ………………..).
  • Patients with placental separation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Cali G, Forlani F, Giambanco L, Amico ML, Vallone M, Puccio G, Alio L. Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta. Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:36-41. doi: 10.1016/j.ejogrb.2014.05.007. Epub 2014 May 21.

MeSH Terms

Conditions

Placenta Accreta

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases

Central Study Contacts

Ahmed Gamal Ahmed Saleh, resident doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor Obsetitric and Gynacology

Study Record Dates

First Submitted

November 27, 2024

First Posted

December 2, 2024

Study Start

January 1, 2025

Primary Completion

January 1, 2026

Study Completion

February 1, 2026

Last Updated

December 2, 2024

Record last verified: 2024-11